Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The ICPO Theranostics Centers Network is a global initiative established by the ICPO Foundation to standardize and expand access to radiotheranostics in precision oncology. The network focuses on bridging the gap between innovative radiopharmaceutical development and clinical application by providing certified infrastructure and standardized treatment protocols. It offers a comprehensive framework for healthcare providers, including the ICPO Academy for specialized training and a certification process for theranostics centers. By fostering a worldwide community of experts, the organization aims to ensure that advanced targeted radionuclide therapies are available to patients globally, regardless of geographic location. Their primary focus areas include the treatment of prostate cancer and neuroendocrine tumors using diagnostic and therapeutic pairs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ICPO Theranostics Centers Network.